Dynavax Technologies
DVAX
#5486
Rank
$1.28 B
Marketcap
$10.96
Share price
-0.09%
Change (1 day)
-14.97%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : $0.64 Billion USD

According to Dynavax Technologies 's latest financial reports the company has $0.64 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.71 B-3.84%
2023-12-31$0.74 B18.88%
2022-12-31$0.62 B14.37%
2021-12-31$0.54 B230.81%
2020-12-31$0.16 B9.26%
2019-12-31$0.15 B3.79%
2018-12-31$0.14 B-24.14%
2017-12-31$0.19 B135.65%
2016-12-31$81.41 M-58.49%
2015-12-31$0.19 B59.9%
2014-12-31$0.12 B-35.23%
2013-12-31$0.18 B51.34%
2012-12-31$0.12 B9.8%
2011-12-31$0.11 B57.94%
2010-12-31$72.15 M96.5%
2009-12-31$36.72 M-46.38%
2008-12-31$68.47 M-22.41%
2007-12-31$88.24 M21.17%
2006-12-31$72.83 M-3.03%
2005-12-31$75.11 M14.07%
2004-12-31$65.84 M126.29%
2003-12-31$29.09 M-1.06%
2002-12-31$29.41 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Agenus
AGEN
$3.45 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$3.96 B 511.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$18.21 B 2,711.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$7.34 B 1,034.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$8.18 B 1,163.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
$4.44 B 586.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$14.98 B 2,213.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$2.20 B 240.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
$9.44 B 1,357.98%๐Ÿ‡บ๐Ÿ‡ธ USA